Fineline Cube

Follow:
14778 Articles
Jiangxi Province to Implement Direct Medical Insurance Fund Payments for NRDL Drugs from December 2024
Policy / Regulatory

Jiangxi Province to Implement Direct Medical Insurance Fund Payments for NRDL Drugs from December 2024

BMS Launches Cardiac Myosin Inhibitor Camzyos in China for Obstructive Hypertrophic Cardiomyopathy
CompanyDrug

BMS Launches Cardiac Myosin Inhibitor Camzyos in China for Obstructive Hypertrophic Cardiomyopathy

Boston Scientific Reports 19.5% YOY Increase in Q3 Net Sales, Driven by New Product Launches and Market Expansion
Company

Boston Scientific Reports 19.5% YOY Increase in Q3 Net Sales, Driven by New Product Launches and Market Expansion

Hengrui Medicine Considers HKEX Secondary Listing Amid Financing Challenges in Mainland China
Company

Hengrui Pharmaceuticals Considers HKEX Secondary Listing Amid Financing Challenges in Mainland China

Everest Medicines’ Velsipity Approved for Use in Select Hospitals in China’s Greater Bay Area
CompanyDrug

Everest Medicines’ Velsipity Approved for Use in Select Hospitals in China’s Greater Bay Area

Daiichi Sankyo’s Pexidartinib Poised for Priority Review in China for TGCT Treatment
CompanyDrug

Daiichi Sankyo’s Pexidartinib Poised for Priority Review in China for TGCT Treatment

AbbVie and Gedeon Richter Expand Partnership to Develop Novel Neuropsychiatric Targets
CompanyDeals

AbbVie and Gedeon Richter Expand Partnership to Develop Novel Neuropsychiatric Targets

Asieris Pharmaceuticals Gets FDA Green Light for USP1 Inhibitor APL-2302 in Advanced Solid Tumors
CompanyDrug

Asieris Pharmaceuticals Gets FDA Green Light for USP1 Inhibitor APL-2302 in Advanced Solid Tumors

Henlius Biotech Commences Global Phase III Trial for Serplulimab in First-Line Metastatic Colorectal Cancer
CompanyDrug

Henlius Biotech Commences Global Phase III Trial for Serplulimab in First-Line Metastatic Colorectal Cancer

ImmuneOnco Biopharmaceuticals Initiates Phase Ib Study for Dual-Target Therapy in Systemic Lupus Erythematosus
CompanyDrug

ImmuneOnco Biopharmaceuticals Initiates Phase Ib Study for Dual-Target Therapy in Systemic Lupus Erythematosus

China's NHSA Sets October Dates for National Reimbursement Drug List Negotiations and Price Bidding
Policy / Regulatory

China’s NHSA Sets October Dates for National Reimbursement Drug List Negotiations and Price Bidding

Sanofi’s Dupixent Demonstrates Positive Results in Phase III Study for Chronic Urticaria
CompanyDrug

Sanofi’s Dupixent Demonstrates Positive Results in Phase III Study for Chronic Urticaria